Gene sequencer and software platform provider Ultima Genomics has partnered with bioinformatics startup Genome Insight to bring affordable whole-genome sequencing solutions to cancer patients.
Genome Insight will join the early access program for Ultima's high-throughput next-generation sequencing (NGS) instrument platform, the UG 100, and optimize its whole-genome bioinformatics solution for Ultima's sequencing technology. By combining Genome Insight's proprietary bioinformatics with Ultima's low-cost sequencing, whole-genome sequencing will become an affordable option for cancer patients. This approach will enable the delivery of curated whole-genome sequencing reports to patients and physicians at a lower cost than conventional NGS panels.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.